Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
Journal for Immunotherapy of Cancer
|
June 7, 2020
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Paolo Antonio Ascierto, Michele Del Vecchio, Andrzej Mackiewicz, et al.
The Lancet. Oncology
|
April 1, 2017
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Paolo A Ascierto, Michele Del Vecchio, Caroline Robert, et al.
The New England Journal of Medicine
|
October 9, 2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Archives of Dermatology
|
September 17, 2008
Dermoscopic evaluation of amelanotic and hypomelanotic melanoma
Scott W Menzies, Juergen Kreusch, Karen Byth, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
Dermatology Practical & Conceptual
|
December 19, 2022
Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society
Teresa Russo, Vincenzo Piccolo, Elvira Moscarella, et al.
Dermatology Practical & Conceptual
|
July 5, 2023
Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna
Caterina Longo, Cristian Navarrete-Dechent, Philipp Tschandl, et al.
Archives of Dermatology
|
July 18, 2012
Prognostic factors of paraneoplastic pemphigus
Sandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.
European Journal of Dermatology : EJD
|
October 14, 2020
Inequalities in the patterns of dermoscopy use and training across Europe: conclusions of the Eurodermoscopy pan-European survey
Ana-Maria Forsea, Philipp Tschandl, Iris Zalaudek, et al.
Nature Communications
|
December 8, 2025
Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study
Konstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
Journal for Immunotherapy of Cancer
|
June 7, 2020
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Paolo Antonio Ascierto, Michele Del Vecchio, Andrzej Mackiewicz, et al.
The Lancet. Oncology
|
April 1, 2017
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Paolo A Ascierto, Michele Del Vecchio, Caroline Robert, et al.
The New England Journal of Medicine
|
October 9, 2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.
Archives of Dermatology
|
September 17, 2008
Dermoscopic evaluation of amelanotic and hypomelanotic melanoma
Scott W Menzies, Juergen Kreusch, Karen Byth, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
Dermatology Practical & Conceptual
|
December 19, 2022
Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society
Teresa Russo, Vincenzo Piccolo, Elvira Moscarella, et al.
Dermatology Practical & Conceptual
|
July 5, 2023
Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna
Caterina Longo, Cristian Navarrete-Dechent, Philipp Tschandl, et al.
Archives of Dermatology
|
July 18, 2012
Prognostic factors of paraneoplastic pemphigus
Sandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.
European Journal of Dermatology : EJD
|
October 14, 2020
Inequalities in the patterns of dermoscopy use and training across Europe: conclusions of the Eurodermoscopy pan-European survey
Ana-Maria Forsea, Philipp Tschandl, Iris Zalaudek, et al.
Nature Communications
|
December 8, 2025
Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study
Konstantinos Lallas, Harald Kittler, Philipp Tschandl, et al.
Page
of 23